Dermatology And Therapy SCIE

国际简称：DERMATOLOGY THER 参考译名：皮肤科和治疗

主要研究方向：Medicine-Dermatology 非预警期刊审稿周期： 6 Weeks

《皮肤科和治疗》(Dermatology And Therapy)是一本由Springer Healthcare出版的以Medicine-Dermatology为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q1 JCR分区
187 年发文量
3.5 IF影响因子
开放是否OA
2011 创刊年份
12 issues per year 出版周期
English 出版语言

Dermatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols, and short communications. Dermatology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an International and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. The journal appeals to a global audience and receives submissions from all over the world.

[ 查看全部 ]

投稿咨询加急咨询

Dermatology And Therapy期刊信息

ISSN：2193-8210
出版语言：English
是否OA：开放
E-ISSN：2190-9172
出版地区：Germany
是否预警：否
出版商：Springer Healthcare
出版周期：12 issues per year
创刊时间：2011
开源占比：0.992
Gold OA文章占比：98.75%
OA被引用占比：1
出版国人文章占比：0.04
出版撤稿占比：0
研究类文章占比：75.94%

Dermatology And Therapy CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

1.424

1.328

学科类别	分区	排名	百分位
大类：Medicine 小类：Dermatology	Q1	17 / 142	88%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Dermatology And Therapy中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	DERMATOLOGY 皮肤病学	3区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	DERMATOLOGY 皮肤病学	2区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	DERMATOLOGY 皮肤病学	3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	DERMATOLOGY 皮肤病学	3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	DERMATOLOGY 皮肤病学	3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	DERMATOLOGY 皮肤病学	3区

Dermatology And Therapy JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：DERMATOLOGY	SCIE	Q1	20 / 94	79.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：DERMATOLOGY	SCIE	Q1	19 / 94	80.32%

Dermatology And Therapy历年数据统计

影响因子

中科院分区

Dermatology And Therapy中国学者发文选摘

1、Design of Effisayil (TM) 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis
Author: Morita, Akimichi; Choon, Siew Eng; Bachelez, Herve; Anadkat, Milan J.; Marrakchi, Slaheddine; Zheng, Min; Tsai, Tsen-Fang; Turki, Hamida; Hua, Harry; Rajeswari, Sushmita; Thoma, Christian; Burden, A. David

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 347-359. DOI: 10.1007/s13555-022-00835-6
2、Effect of 30% Supramolecular Salicylic Acid Peel on Skin Microbiota and Inflammation in Patients with Moderate-to-Severe Acne Vulgaris
Author: Shao, Xinyi; Chen, Yangmei; Zhang, Lingzhao; Zhang, Yujie; Ariyawati, Asoka; Chen, Tingqiao; Chen, Jiayi; Liu, Lin; Pu, Yihuan; Li, Yuxin; Chen, Jin

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 155-168. DOI: 10.1007/s13555-022-00844-5
3、Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
Author: Yu, Chen; Wang, Gang; Burge, Russel T.; Ye, Erjia; Dou, Guanshen; Li, Jinnan; Harrison, Ryan W.; McLean, Robert R.; Kerti, Samantha J.; Bagel, Jerry

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 187-206. DOI: 10.1007/s13555-022-00843-6
4、Application of Comfort Therapy under eCASH Concept in Acute and Chronic Wound Treatment
Author: Shi, Shuting; Wei, Jiayu; Lyu, Guozhong; Zhong, Xiaohui; Zhu, Lihong; Yang, Minlie

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 299-314. DOI: 10.1007/s13555-022-00852-5
5、Effectiveness and Safety of Guselkumab for the Treatment of Psoriasis in Real-World Settings at 52 weeks: A Retrospective, Observational, Multicenter Study from China
Author: Yang, Jing; Hu, Kun; Li, Xingyu; Hu, Jingjin; Tan, Minjia; Zhang, Mi; Kuang, Yehong; Lv, Chengzhi; Chen, Junchen

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 2, pp. 477-485. DOI: 10.1007/s13555-022-00869-w
6、Efficacy, Safety and Pharmacokinetics of IL-17 Monoclonal Antibody Injection (AK111) in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blinded, Placebo-Controlled Phase Ib Multidose Escalation Clinical Study
Author: Jiang, Congjun; Zhou, Huan; Zhang, Wanlu; Xia, Yu; Li, Baiyong; Ni, Xiang; Wang, Guoqin; Zhang, Wenhui; Chen, Benchao; He, Zhimei; Zhang, Min; Chen, Rui; Jin, Hongzhong; Deng, Liehua

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 2, pp. 555-567. DOI: 10.1007/s13555-022-00880-1
7、An Intelligent Diagnostic Model for Melasma Based on Deep Learning and Multimode Image Input
Author: Liu, Lin; Liang, Chen; Xue, Yuzhou; Chen, Tingqiao; Chen, Yangmei; Lan, Yufan; Wen, Jiamei; Shao, Xinyi; Chen, Jin

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 2, pp. 569-579. DOI: 10.1007/s13555-022-00874-z
8、Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective
Author: Chu, Chia-Yu; Yao, Tsung-Chieh; Shih, I. -Hsin; Yang, Chin-Yi; Chin, Chan Lee; Ibrahim, Sabeera Begum Binti Kader; Thevarajah, Suganthi; Fon, Leong Kin; Ho, Marco Hok-Kung; Mo, Chow Chung; Yu, Chow Pok; Loo, Steven King-Fan; Luger, Thomas

Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 3, pp. 717-727. DOI: 10.1007/s13555-022-00886-9